DR. WALTONS

Manufacturer: Dr. Waltons, Incorporated
Effective date: 2012-02-21
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: legacy-cache
Hydrated at: 2026-08-02 01:49:31

Label at a glance#

ProductDR. WALTONS BABY POWDER

Active ingredientALPHA-TOCOPHEROL, ZINC OXIDE

Label structure9 sections

Label contents#

Full prescribing information#

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF CHILDREN'S REACH. AVOID BABY'S EYES, NOSE AND MOUTH.

OTC - PURPOSE SECTION

GREAT FOR YOUR BABY: PREVENTS AND SOOTHES DIAPER RASH, ELIMINATES ODOR. USE AFTER EVERY BATH AND DIAPER CHANGE.

GREAT FOR YOU: USE DAILY FOR SOFT, IRRITATION-FREE SKIN. REDUCES CHAFING AND ABSORBS MOISTURE. GREAT FOR ELIMINATING SAND AND MOISTURE AFTER A DAY AT THE BEACH!

OTC - DO NOT USE SECTION

CAUTION: KEEP OUT OF CHILDREN'S REACH. AVOID BABY'S EYES, NOSE AND MOUTH. NOT FOR USE ON BROKEN SKIN. IF IRRITATION DEVELOPS, PLEASE DISCONTINUE USE.

HYPOALLERGENIC; DERMATOLOGIST AND ALLERGY TESTED; PEDIATRICIAN TESTED

WARNINGS SECTION

IF IRRITATION DEVELOPS, PLEASE DISCONTINUE USE.

INDICATIONS & USAGE SECTION

PREVENTS AND SOOTHES DIAPER RASH, ELIMINATES ODOR

DOSAGE & ADMINISTRATION SECTION

SHAKE POWDER ONTO HANDS AND GENTLY RUB ONTO SKIN

INACTIVE INGREDIENT SECTION

TALC

OTC - ACTIVE INGREDIENT SECTION

VITAMIN E (ALPHA-TOCOPHEROL), ZINC OXIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image of front labelimage of back labelEnter section text here

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
76271-001-02	2025-01-16	C162847	48780-1	97449f38-ce2d-f6ea-e053-dbdaa90aa703	DRUG FACTS
76271-001-24	2025-01-16	C162847	48780-1	97449f38-ce2d-f6ea-e053-dbdaa90aa703	DRUG FACTS
76271-001-02	2019-11-13	C162847	48780-1	97449f38-ce2d-f6ea-e053-dbdaa90aa703	DRUG FACTS
76271-001-24	2019-11-13	C162847	48780-1	97449f38-ce2d-f6ea-e053-dbdaa90aa703	DRUG FACTS

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALPHA-TOCOPHEROL	ACTIVE INGREDIENT	H4N855PNZ1	4
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	4
ALPHA-TOCOPHEROL	ACTIVE MOIETY	H4N855PNZ1	4
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

DR. WALTONS BABY POWDER
TALC
ALPHA-TOCOPHEROL
ZINC OXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
76271-001	76271-001-24, 76271-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TALC	7SEV7J4R1U	IACT
ALPHA-TOCOPHEROL	H4N855PNZ1	ACTIB
ZINC OXIDE	SOI2LOH54Z	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 35 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
TALC	TALC	7SEV7J4R1U	TABLET, FILM COATED / ORAL		91 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE, FOR SUSPENSION / ORAL		296 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	SUSPENSION / ORAL		234 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, COATED PELLETS / ORAL	14 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	PELLET / ORAL		69 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		60 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE / ORAL		349 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	SUSPENSION, EXTENDED RELEASE / ORAL		46 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		357 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GUM, CHEWING / BUCCAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, EXTENDED RELEASE / ORAL		300 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / ORAL	1000 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, COATED / ORAL	320.75 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	OINTMENT / TOPICAL	74.6 %w/w		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FOR SUSPENSION / ORAL		24 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, DELAYED RELEASE / ORAL		420 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	DROPS / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE PARTICLES / ORAL		56 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, COATED, EXTENDED RELEASE / ORAL		20 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING / ORAL		80 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, EXTENDED RELEASE / ORAL		5119 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		18 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE / ORAL		322 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE / ORAL		729 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	LOZENGE / ORAL		50 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / SUBLINGUAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	POWDER / TOPICAL		9235 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, COATED / ORAL		87 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	ELIXIR / ORAL	4.5 mg/5ml		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, CHEWABLE / ORAL		202 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / RECTAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	POWDER, FOR SUSPENSION / ORAL		735 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE, DELAYED RELEASE / ORAL		525 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / BUCCAL	15 mg		Exact identifier — unii candidate 35 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
28ed8cf6-18d2-5395-e063-6394a90a8d7f			4c0dac58-34b5-418a-a54c-5ffcb690771f	2024-12-10	Warnings	Exact identifier spl set id: 4c0dac58-34b5-418a-a54c-5ffcb690771f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.